Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Dydrogesterone versus micronized vaginal progesterone as luteal phase support after fresh embryo transfer in IVF].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Healthy Aging Biomarkers: The INSPIRE's Contribution.

The Journal of frailty & aging·2021
Same author

The INSPIRE Research Initiative: A Program for GeroScience and Healthy Aging Research Going from Animal Models to Humans and the Healthcare System.

The Journal of frailty & aging·2021
Same author

The INSPIRE Bio-Resource Research Platform for Healthy Aging and Geroscience: Focus on the Human Translational Research Cohort (The INSPIRE-T Cohort).

The Journal of frailty & aging·2021
Same author

Towards a Large-Scale Assessment of the Relationship between Biological and Chronological Aging: The INSPIRE Mouse Cohort.

The Journal of frailty & aging·2021
Same author

Regulation of hepatokine gene expression in response to fasting and feeding: Influence of PPAR-α and insulin-dependent signalling in hepatocytes.

Diabetes & metabolism·2019

Related Experiment Video

Updated: May 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

[Menopause and cardiovascular risk].

A-L Dessapt1, P Gourdy

  • 1Centre d'assistance médicale à la procréation, centre intercommunal de Créteil, 40 avenue de Verdun, Créteil, France. anne-lucie.dessapt@hotmail.fr

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|October 9, 2012
PubMed
Summary

Hormone replacement therapy (HRT) may offer cardiovascular benefits for postmenopausal women, particularly when initiated early. Transdermal estrogen and careful progestogen selection are key to maximizing benefits and minimizing risks.

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Related Experiment Videos

Last Updated: May 18, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

Area of Science:

  • Cardiovascular Health
  • Endocrinology
  • Menopause Management

Background:

  • Estrogenic deficiency during menopause increases risks of osteoporosis, metabolic issues, and cardiovascular complications.
  • Initial concerns regarding hormone replacement therapy (HRT) and cardiovascular risk, stemming from WHI and HERS studies, have been nuanced by subsequent analyses.
  • HRT's influence on cardiovascular risk factors, including lipid profiles and insulin resistance, is a critical area of study.

Purpose of the Study:

  • To re-evaluate the cardiovascular risk-benefit profile of HRT in postmenopausal women.
  • To explore the differential effects of oral versus transdermal estrogen administration on cardiovascular health.
  • To understand the role of the timing of HRT initiation and the choice of progestogen in cardiovascular outcomes.

Main Methods:

  • Review of findings from major controlled studies (WHI, HERS) and subsequent post-hoc analyses.
  • Analysis of the impact of oral and transdermal estrogen on lipid profiles (LDL, HDL, triglycerides), insulin resistance, and diabetes incidence.
  • Examination of the pro-inflammatory and prothrombotic effects of oral estrogens versus transdermal administration.
  • Consideration of the stage of atheromatous plaque formation and the influence of estradiol.
  • Evaluation of the impact of different progestogens on estradiol's cardiovascular benefits.

Main Results:

  • Oral estrogens decrease LDL, increase HDL and triglycerides, and reduce insulin resistance and type 2 diabetes risk, but may have pro-inflammatory and prothrombotic effects.
  • Transdermal estrogen administration appears to mitigate the pro-inflammatory and prothrombotic risks associated with oral estrogens.
  • Estradiol demonstrates a protective vascular effect during early atherogenesis but may be harmful if plaques are already formed.
  • Post-hoc analyses suggest HRT offers vascular benefits if initiated early in menopause, within an 'opportunity window', before advanced plaque formation.
  • Transdermal estrogens are not associated with increased risks of thromboembolism or stroke.
  • The choice of progestogen is crucial, as some can attenuate or negate the beneficial effects of estradiol on lipid profiles and atheroma prevention.

Conclusions:

  • HRT can provide cardiovascular benefits, particularly when initiated early post-menopause via the transdermal route, with careful progestogen selection.
  • The timing of HRT initiation relative to menopause onset and the presence of atherosclerosis is critical for achieving vascular benefits.
  • Personalized HRT prescriptions, using the lowest effective dose combined with lifestyle modifications, are recommended.